National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology

被引：172

作者：

Schneider, LS ^{[1
]}

Tariot, PN ^{[1
]}

Lyketsos, CG ^{[1
]}

Dagerman, KS ^{[1
]}

Davis, KL ^{[1
]}

Davis, S ^{[1
]}

Hsiao, JK ^{[1
]}

Jeste, DV ^{[1
]}

Katz, IR ^{[1
]}

Olin, JT ^{[1
]}

Pollock, BG ^{[1
]}

Rabins, PV ^{[1
]}

Rosenheck, RA ^{[1
]}

Small, GW ^{[1
]}

Lebowitz, B ^{[1
]}

Lieberman, JA ^{[1
]}

机构：

[1] Univ N Carolina, NIMH, Clin Antipsychot Trials Intervent Effectiveness P, Chapel Hill, NC 27599 USA

来源：

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2001年 / 9卷 / 04期

关键词：

D O I：

10.1176/appi.ajgp.9.4.346

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

The authors describe the development of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) protocol for Alzheimer disease (AD), a trial developed in collaboration with the National Institute of Mental Health (NIMH), assessing the effectiveness of atypical antipsychotics for psychosis and agitation occurring in AD outpatients. They provide an overview of the methodology utilized in the trial as well as the clinical-outcomes and effectiveness measures that were implemented.

引用

页码：346 / 360

页数：15

共 44 条

[1] A RATING-SCALE FOR DRUG-INDUCED AKATHISIA [J].